Research programme: Staphylococcus epidermidis vaccine - Nabi
Alternative Names: Staphylococcus epidermidis (GP-1) vaccineLatest Information Update: 11 Jun 2008
At a glance
- Originator Nabi Biopharmaceuticals
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Staphylococcal infections
Most Recent Events
- 11 Jun 2008 Discontinued - Preclinical for Staphylococcal infections in USA (unspecified route)
- 07 Jun 2007 Preclinical trials in Staphylococcal infections in USA (unspecified route)